million. The hospital and service revenues grew by 1.26% comprising 1.41% decrease of existing hospital operation and 25.56% increase of service revenues from the subsidiary (Asia Medical & Agricultural

the growth rate of company’s revenue; therefore, SG&A/Sales decrease from 11.06% in Q1/2018 to 10.13% in Q1/2019. 3. Financial Expenses The financial expenses in Q1/2019 were 5.94 million baht increased

in the same period in 2018. Revenues from sales decrease from Baht 8.39 million for the three-month period financial statement ended June 30, 2018 to Baht 1.92 million for the three-month period

of December 31, 2017 Financial Statement Consolidate financial statement % revenue from sales 2017 2016 increase(decrease) 2017 2016 Revenues from sales 295.89 708.62 (412.73 ) (58.24%) 100.00% 100.00

months, end of December 31, 2017 Financial Statement Consolidate financial statement % revenue from sales 2017 2016 increase(decrease) 2017 2016 Revenues from sales 295.89 708.62 (412.73 ) (58.24%) 100.00

decrease in all expenses. Operating results and financial position compared September 30, 2017 and September 30, 2018 THB : Million 2017 2018 % of Change increase (decrease) Sale 433.18 466.86 7.78% Cost of

its subsidiaries for the six-month period ended 30 June 2018 represented a loss of Baht 259.31 million. Compared to the same period of 2017, the loss was Baht 482.86 million (restated), a decrease loss

decrease loss of 83%. The Company would like to clarify a significance change of Group’s operation results were summarized as follows 1. Revenue from sales of goods and rendering of services for the nine

Baht) For 9 months, end of September 30, 2018 Financial Statement Consolidate financial statement % revenue from sales Q3/2018 Q3/2017 increase(decrease) Q3/2018 Q3/2017 Revenues from sales 140.51 218.76

, end of December 31, 2018 Financial Statement Consolidate financial statement % revenue from sales Q4/2018 Q4/2017 increase(decrease) Q4/2018 Q4/2017 Revenues from sales 175.66 295.89 (120.23 ) (40.63